Authors:
TUTT AL
FRENCH RR
ILLIDGE TM
HONEYCHURCH J
MCBRIDE HM
PENFOLD CA
FEARON DT
PARKHOUSE RME
KLAUS GGB
GLENNIE MJ
Citation: Al. Tutt et al., MONOCLONAL-ANTIBODY THERAPY OF B-CELL LYMPHOMA - SIGNALING ACTIVITY ON TUMOR-CELLS APPEARS MORE IMPORTANT THAN RECRUITMENT OF EFFECTORS, The Journal of immunology (1950), 161(6), 1998, pp. 3176-3185
Authors:
WURFLEIN D
DECHANT M
STOCKMEYER B
TUTT AL
HU PS
REPP R
KALDEN JR
VANDEWINKEL JGJ
EPSTEIN AL
VALERIUS T
GLENNIE M
GRAMATZKI M
Citation: D. Wurflein et al., EVALUATING ANTIBODIES FOR THEIR CAPACITY TO INDUCE CELL-MEDIATED LYSIS OF MALIGNANT B-CELLS, Cancer research, 58(14), 1998, pp. 3051-3058
Authors:
HONEYCHURCH J
CRUISE A
TUTT AL
GLENNIE MJ
Citation: J. Honeychurch et al., BISPECIFIC AB THERAPY OF B-CELL LYMPHOMA - TARGET-CELL SPECIFICITY OFANTIBODY DERIVATIVES APPEARS CRITICAL IN DETERMINING THERAPEUTIC OUTCOME, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 171-173
Authors:
HEIJNEN IAFM
RIJKS LJM
SCHIEL A
STOCKMEYER B
VANOJIK HH
DECHANT M
VALERIUS T
KELER T
TUTT AL
GLENNIE MJ
VANROYEN EA
CAPEL PJA
VANDEWINKEL JGJ
Citation: Iafm. Heijnen et al., GENERATION OF HER-2 NEU-SPECIFIC CYTOTOXIC NEUTROPHILS IN-VIVO - EFFICIENT ARMING OF NEUTROPHILS BY COMBINED ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR AND FC-GAMMA RECEPTOR-I BISPECIFIC ANTIBODIES/, The Journal of immunology, 159(11), 1997, pp. 5629-5639
Authors:
FRENCH RR
BELL AJ
HAMBLIN TJ
TUTT AL
GLENNIE MJ
Citation: Rr. French et al., RESPONSE OF B-CELL LYMPHOMA TO A COMBINATION OF BISPECIFIC ANTIBODIESAND SAPORIN, Leukemia research, 20(7), 1996, pp. 607-617
Citation: Al. Tutt et al., ACTIVATION AND PREFERENTIAL EXPANSION OF RAT CYTOTOXIC (CD8) T-CELLS IN-VITRO AND IN-VIVO WITH A BISPECIFIC (ANTI-TCR-ALPHA BETA X ANTI-CD2)F(AB')(2) ANTIBODY/, The Journal of immunology, 155(6), 1995, pp. 2960-2971